Free Trial

Zimmer Biomet (ZBH) Stock Forecast & Price Target

→ Truth about Trump you’ve never heard (From Porter & Company) (Ad)
Free zbh Stock Alerts
$119.33
+0.33 (+0.28%)
(As of 05/22/2024 ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability

Zimmer Biomet - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Hold
Based on 15 Analyst Ratings

Consensus Price Target

$134.40
12.63% Upside
High Forecast$155.00
Average Forecast$134.40
Low Forecast$120.00
TypeCurrent Forecast
5/24/23 to 5/23/24		1 Month Ago
4/24/23 to 4/23/24		3 Months Ago
2/23/23 to 2/23/24		1 Year Ago
5/24/22 to 5/24/23
Consensus Rating
Hold
Hold
Hold
Hold
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
6 Buy rating(s)
5 Buy rating(s)
7 Buy rating(s)
6 Buy rating(s)
Hold
8 Hold rating(s)
9 Hold rating(s)
9 Hold rating(s)
8 Hold rating(s)
Sell
1 Sell rating(s)
1 Sell rating(s)
2 Sell rating(s)
2 Sell rating(s)
Consensus Price Target$134.40$139.39$138.20$143.67
Forecasted Upside12.63% Upside12.55% Upside12.63% Upside10.75% Upside
Get Zimmer Biomet Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for ZBH and its competitors with MarketBeat's FREE daily newsletter.

ZBH Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

ZBH Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Zimmer Biomet Stock vs. The Competition

TypeZimmer BiometMedical CompaniesS&P 500
Consensus Rating Score
2.33
2.69
2.49
Consensus RatingHoldModerate BuyHold
Predicted Upside12.63% Upside706.38% Upside8.72% Upside
News Sentiment RatingPositive News
Neutral News
Positive News

Recent Analyst Forecasts and Stock Ratings

Export to Excel
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
5/21/2024Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating		D. Toung
Subscribe to MarketBeat All Access for the recommendation accuracy rating		UpgradeHold ➝ Buy$150.00+25.89%
5/17/2024Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Reiterated RatingHold
5/3/2024Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Lower TargetHold ➝ Hold$137.00 ➝ $130.00+8.35%
5/3/2024Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Boost TargetOutperform ➝ Outperform$150.00 ➝ $155.00+29.43%
4/4/2024Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Boost TargetIn-Line ➝ In-Line$125.00 ➝ $130.00+0.36%
4/3/2024Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Boost TargetNeutral ➝ Neutral$134.00 ➝ $140.00+8.12%
2/23/2024Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Reiterated RatingHold ➝ Hold$130.00+0.61%
2/12/2024Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Boost TargetUnderweight ➝ Underweight$120.00 ➝ $130.00+3.83%
2/9/2024JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Boost TargetNeutral ➝ Neutral$115.00 ➝ $125.00+1.90%
2/9/2024Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Reiterated RatingOutperform ➝ Outperform$140.00+15.14%
1/3/2024Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Boost TargetOutperform ➝ Outperform$133.00 ➝ $137.00+13.70%
12/4/2023Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Boost TargetEqual Weight ➝ Equal Weight$120.00 ➝ $125.00+6.56%
11/13/2023JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Lower TargetMarket Outperform ➝ Market Outperform$160.00 ➝ $140.00+31.14%
10/20/2023Roth Mkm
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Initiated CoverageNeutral$120.00+14.56%
8/28/2023BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 UpgradeNeutral ➝ Buy$139.00+20.62%
8/2/2023UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Boost Target$116.00 ➝ $125.00-3.84%
5/18/202322nd Century Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Reiterated RatingMaintains
5/18/2023888
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Reiterated RatingMaintains
5/18/2023Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Boost Target$160.00 ➝ $165.00+22.19%
5/3/202358.com
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Reiterated RatingMaintains
5/3/2023Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Boost Target$121.00 ➝ $147.00+4.13%
5/3/2023FIG Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 UpgradeNeutral
5/3/2023Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 UpgradeUnderperform ➝ Neutral
5/3/2023Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Boost Target$145.00 ➝ $172.00+20.27%
5/3/2023Sanford C. Bernstein
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Boost Target$136.00 ➝ $152.00+6.29%
3/31/2023Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 UpgradeUnderperform ➝ Hold$115.00 ➝ $130.00+2.56%
3/9/2023Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 UpgradeNeutral ➝ Overweight$135.00 ➝ $145.00+18.51%
2/6/2023Loop Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Boost Target$125.00 ➝ $140.00+8.15%
11/23/2022Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 UpgradeUnderweight ➝ Equal Weight$116.00 ➝ $124.00+7.52%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 07:42 AM ET.

ZBH Frequently Asked Questions

What is Zimmer Biomet's stock forecast and purchase recommendation?

According to the research reports of 15 Wall Street equities research analysts, the average twelve-month stock price forecast for Zimmer Biomet is $134.40, with a high forecast of $155.00 and a low forecast of $120.00. The consensus rating for Zimmer Biomet stock is Hold based on the current 1 sell rating, 8 hold ratings and 6 buy ratings for ZBH. Learn more on ZBH's analyst rating history.

Do Wall Street analysts like Zimmer Biomet more than its competitors?

Analysts like Zimmer Biomet less than other "medical" companies. The consensus rating for Zimmer Biomet is Hold while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how ZBH compares to other companies.

Is Zimmer Biomet being upgraded by Wall Street analysts?

Over the previous 90 days, Zimmer Biomet's stock had 1 upgrade by analysts.

Does Zimmer Biomet's stock price have much upside?

According to analysts, Zimmer Biomet's stock has a predicted upside of 11.61% based on their 12-month stock forecasts.

What analysts cover Zimmer Biomet?

Zimmer Biomet has been rated by research analysts at Argus, Canaccord Genuity Group, Citigroup, Evercore ISI, Needham & Company LLC, Oppenheimer, and Truist Financial in the past 90 days.


Stock Forecasts and Research Tools

Related Companies:
Today's Ratings:
Top Rated Stocks:
More Ratings Tools:
This page (NYSE:ZBH) was last updated on 5/23/2024 by MarketBeat.com Staff

From Our Partners
This could mean the end of the U.S dollar…
Colonial Metals
Exposed: 10 CENT Crypto to Explode May 20th?
True Market Insiders
Truth about Trump you’ve never heard
Porter & Company
Gold Set to EXPLODE!
Gold Safe Exchange
Bitcoin’s Biggest Year Yet
Paradigm Press
Dividend-like income from non-dividend stocks
Unstoppable Prosperity
[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks
Crypto 101 Media
Write this ticker symbol down…
StocksToTrade